A Population-Based Study of the Effectiveness of Stereotactic Ablative Radiotherapy Versus Conventional Fractionated Radiotherapy for Clinical Stage I Non-Small Cell Lung Cancer Patients. Radiology and Oncology, v. 52, n. 2, 23 May2018.